Relmada Therapeutics (RLMD) has had the highest return between March 5, 2025 and March 5, 2026 by a small-cap US stock, returning 1,747.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Relmada Therapeutics (RLMD) | 3/5/2025 - 3/5/2026 | 1,747.41% |
Battalion Oil (BATL) | 3/5/2025 - 3/5/2026 | 1,146.31% |
Babcock & Wilcox Enterprises (BW) | 3/5/2025 - 3/5/2026 | 1,056.86% |
Santacruz Silver Mining Ltd Common Shares (SCZM) | 3/5/2025 - 3/5/2026 | 951.99% |
Nanobiotix (NBTX) | 3/5/2025 - 3/5/2026 | 947.52% |
Ventyx Biosciences (VTYX) | 3/5/2025 - 3/5/2026 | 845.95% |
CytomX Therapeutics (CTMX) | 3/5/2025 - 3/5/2026 | 668.18% |
IsoEnergy (ISOU) | 3/5/2025 - 3/5/2026 | 644.67% |
United States Antimony (UAMY) | 3/5/2025 - 3/5/2026 | 617.04% |
Zepp Health (ZEPP) | 3/5/2025 - 3/5/2026 | 613.82% |
Kodiak Sciences (KOD) | 3/5/2025 - 3/5/2026 | 604.46% |
International Tower Hill Mines (THM) | 3/5/2025 - 3/5/2026 | 602.76% |
Almonty Industries Inc Common Shares (ALM) | 3/5/2025 - 3/5/2026 | 595.11% |
Avino Silver & Gold Mines (ASM) | 3/5/2025 - 3/5/2026 | 583.46% |
Tango Therapeutics (TNGX) | 3/5/2025 - 3/5/2026 | 571.2% |
Alto Neuroscience (ANRO) | 3/5/2025 - 3/5/2026 | 569.69% |
RAPT Therapeutics (RAPT) | 3/5/2025 - 3/5/2026 | 559.15% |
Palvella Therapeutics (PVLA) | 3/5/2025 - 3/5/2026 | 550.3% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | 3/5/2025 - 3/5/2026 | 539.54% |
Zura Bio Limited - Class A Ordinary shares (ZURA) | 3/5/2025 - 3/5/2026 | 513.16% |
Newegg Commerce (NEGG) | 3/5/2025 - 3/5/2026 | 499.44% |
Tanzanian Royalty Exploration (TRX) | 3/5/2025 - 3/5/2026 | 498.64% |
Olema Pharmaceuticals (OLMA) | 3/5/2025 - 3/5/2026 | 475.41% |
DBV Technologies (DBVT) | 3/5/2025 - 3/5/2026 | 459.95% |
Amprius Technologies (AMPX) | 3/5/2025 - 3/5/2026 | 457.78% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
